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Objective: We sought to determine the results of surgical treatment of patients with
tetralogy of Fallot and pulmonary atresia with or without major aortopulmonary
collateral arteries, to clarify variables affecting early and late mortality, and to
expose late, nonfatal events affecting surgical patients.
Methods: The records of 495 patients operated on from 1977 to 1999 were reviewed.
Patients were separated into those who did not undergo complete repair (group A)
and those who did (group B).
Results: Group A consisted of 160 patients. Eighty-one (51%) had palliative
procedures, 45 (28%) had preliminary surgical stages (unifocalization and right
ventricular outflow tract reconstruction) as initial operations, and 34 (21%) had all
surgical stages but were rejected for complete repair. Early and late mortality were
16.3% (n  26) and 23.1% (n  31), respectively. Mean follow-up was 72.3
months. The presence of major aortopulmonary collateral arteries was a risk factor
for late mortality (P  .0182). Group B consisted of 335 patients. Mean age at
complete repair was 11.3 years (SD, 9.2). One hundred three (30%) patients had
single-stage complete repair, whereas 232 (69%) had staged reconstruction. Twen-
ty-two (6.6%) patients underwent reopening of the ventricular septal defect for high
right ventricular pressure. Early and late mortality were 4.5% (n 15). Risk factors
were a peak right ventricular/left ventricular pressure ratio of greater than 0.7 and
reopening of the ventricular septal defect (P  .05). Late mortality was 16% (n 
51). Mean follow-up was 11.4 years (SD, 7.5). Risk factors included male sex,
nonconfluent central pulmonary arteries, reopening of the ventricular septal defect,
and postrepair conduit exchange (n  137). Ten- and 20-year results were an
actuarial survival of 86% and 75% and freedom from reoperation of 55% and 29%,
respectively.
Conclusions: Surgical repair of patients with simple or complex forms of tetralogy
of Fallot with pulmonary atresia can be achieved with low early mortality. Late
mortality and need for reoperation, especially conduit replacement, continue to
affect the long-term well-being of these patients.
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Patients with tetralogy of Fallot and pulmonaryatresia exhibit the extreme form of the mal-formation, with its associated anomalies af-fecting the pulmonary arterial circulation. Themorphologic features of this anomaly havebeen reported previously.1-3 A characteristic
of these patients is the presence of complex abnormalities of
the pulmonary arterial tree4 and the presence of major
aortopulmonary arterial collateral arteries connecting the
systemic with the pulmonary circulations. The clinical pre-
sentation of these patients is variable, depending on the
magnitude of the pulmonary blood flow, which allows some
patients to maintain an excellent functional status for many
years.5 Nevertheless, the great majority of patients require
surgical treatment for stabilization of their clinical condi-
tion.6 To this date, few reports have dealt with the long-term
results of the surgical treatment of this complex group of
patients.
We sought to determine the early and late results of
surgical treatment and to identify variables that may influ-
ence mortality and the occurrence of late, nonfatal events
affecting the clinical course of patients with tetralogy of
Fallot and pulmonary atresia.
Methods
Palliative procedures were those designed to improve patient
symptomatology; most of these were systemic–pulmonary artery
shunts.
Reconstructive procedures were those designed to modify the
pulmonary arterial morphology and circulation so as to prepare the
patient for complete repair. Right ventricular outflow reconstruc-
tion by means of establishment of right ventricle–pulmonary artery
continuity with a valveless conduit, leaving the ventricular septal
defect open, was used to induce enlargement of hypoplastic, con-
fluent central pulmonary arteries by exposing them to the wide
pulse pressure resulting from the absence of the valve in the
connecting conduit. Unifocalization procedures, designed to cor-
rect the arborization abnormalities associated with the presence of
major aortopulmonary arterial collaterals, were used to eliminate
multiple, extracardiac sources of pulmonary arterial blood flow
while creating a single source that could be accessed at the time of
complete repair.
Complete repair was defined as closure of septal defects (atrial
and ventricular), establishment of unrestricted continuity between
the right ventricle and as many of the pulmonary arterial segments
as possible, and elimination of extracardiac sources of pulmonary
arterial blood flow. Patients who underwent an attempt at complete
repair but had their ventricular septal defect reopened because of
excessively high right ventricular pressure were not considered to
have had complete biventricular repair. Except for a few excep-
tions during the early part of our experience, a valved conduit was
used to establish continuity between the right ventricle and the
pulmonary arteries at the time of complete repair. Conduits used
included porcine valved composite Dacron conduits and cryopre-
served aortic or pulmonary valve homografts. Complete repair was
accomplished with standard techniques of hypothermic cardiopul-
monary bypass. Myocardial protection during periods of aortic
crossclamping was achieved with infusion of cold blood cardiople-
gic solution. Short periods of circulatory arrest were often used
during complex reconstruction of the pulmonary arteries.
The techniques and management protocols used in the surgical
treatment of patients with tetralogy of Fallot and pulmonary atresia
have evolved over the course of the past 3 decades. For most
patients, complete repair by means of closure of the septal defects
and establishment of continuity between the right ventricle and the
largest number of pulmonary arterial segments with a valved
conduit constitutes the ultimate objective of the surgical treatment
of these patients. This goal was achieved during a single surgical
stage when all significant malformations affecting the pulmonary
arterial circulation could be corrected with a median sternotomy
approach and cardiopulmonary bypass. Patients selected for this
approach had relatively simple pulmonary arterial anatomy. Mul-
tiple surgical stages were used when the central pulmonary
arteries were absent, in the presence of significant hypoplasia of
the pulmonary arterial confluence (50% of normal for the central
pulmonary arterial area), when the most proximal portion of
the pulmonary arterial tree could not be accessed easily through
the median sternotomy approach, and/or in the presence of major
arborization abnormalities of the pulmonary arteries associated
with major aortopulmonary arterial collaterals. Surgical stages
used before complete repair included reconstruction of the right
ventricular outflow tract, unifocalization procedures, or both.
When staged surgical interventions were used to prepare the pa-
tient for complete repair, postoperative cardiac catheterization and
angiography were performed to ascertain the success or failure of
the procedure before proceeding with the next surgical stage,
complete repair, or both. After completion of all preliminary
surgical stages, patients selected for complete repair were those in
whom final right ventricular outflow reconstruction would incor-
porate at least 14 pulmonary arterial segments, those with a pre-
dominant left-to-right intracardiac shunt, and those with significant
but repairable residual stenotic areas in the pulmonary arterial tree.
Finally, the relation of the right ventricular to the left ventricular
systolic pressures (peak right ventricular/left ventricular [PRV/
LV] systolic pressure ratio) at the conclusion of the repair was
measured intraoperatively by means of direct needle puncture. If
the ratio was found to be higher than 0.85, the ventricular septal
defect was reopened immediately.
In recent years, we have pursued complete repair in a selected
group of infants and small children with favorable pulmonary
arterial anatomy. For this approach, we have selected patients with
good-sized central pulmonary arteries whose major aortopulmo-
nary arterial collaterals are accessible through the median sternot-
omy approach for complete unifocalization.
Population
The records of 499 patients with tetralogy of Fallot and pulmonary
atresia with or without major aortopulmonary arterial collaterals
who had at least one surgical intervention at the Mayo Clinic from
January 1, 1977, to January 1, 2000, were reviewed. Four patients
did not authorize inclusion in the study and were eliminated from
further analysis. Also excluded from this study were patients with
pulmonary atresia associated with other cardiac abnormalities,
such as univentricular heart, atrioventricular septal defect, hypo-
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plastic right or left ventricle, and discordant atrioventricular or
ventriculoarterial connection.
The patient population was divided into 2 groups. Group A is
composed of 160 patients who have not undergone complete
biventricular repair but have undergone palliative or reconstructive
procedures and may be waiting for complete repair or further
surgical stages or were assessed and rejected for complete repair.
Group B includes 335 patients who have undergone complete
repair in a single surgical stage (96 patients) or after previous
reconstructive procedures (239 patients).
Demographic, morphologic, and surgical data were obtained
from hospital records and entered into the SAS system (SAS
Institute, Inc, Cary, NC). Recent cross-sectional follow-up (94.6%)
was obtained through the Mayo Survey Research Center by means
of telephone calls and written correspondence. Twenty-seven pa-
tients were lost to follow-up, and their last observed episode was
used for calculation purposes.
Statistical Analysis
Survival probabilities and 95% confidence intervals were com-
puted with the Kaplan-Meier method. The prognostic significance
of factors was tested in a univariate model by using the log rank
statistic for categorical covariates and by using the Cox propor-
tional hazards model for continuous and time-dependent covari-
ates. The Cox proportional hazards model was also used to test the
prognostic significance of factors in a multivariate model. Rela-
tionships of factors to perioperative death were evaluated with the
2 test, the Fisher exact test, and the Wilcoxon rank sum test.
Results
The study population is summarized in Figure 1. Group A is
composed of 160 patients who underwent palliative or re-
constructive procedures but had yet to undergo or had been
rejected for complete repair. This group includes 81 patients
who had palliative procedures; 45 patients who had pallia-
tive procedures, reconstructive procedures, or both but had
not yet been assessed for complete repair; and 34 patients
who completed all preliminary surgical stages and were
assessed and rejected for complete repair because of persis-
tent uncorrected abnormalities of the pulmonary arterial
tree, pulmonary vascular obstructive disease, or both. There
were 81 male (50.6%) and 79 female (49.4%) patients.
Morphologic characteristics of these patients are shown in
Table 1. One hundred forty-six (91.5%) patients had major
aortopulmonary collateral arteries. Twenty-three (14.4%)
patients had confluent normal-sized pulmonary arteries. The
surgical procedures and catheter interventional procedures
performed in these patients are shown in Table 2. The
reconstructive procedures included right ventricular outflow
tract reconstruction (98 procedures) and unifocalization op-
erations (98 procedures). Hospital mortality in group A
patients was 16.3% (26 patients). The surgical mortality
improved with increasing surgical experience, as shown in
Figure 2. Causes of early death are shown in Table 3.
Follow-up of these patients from their first surgical proce-
dure, which may have occurred before 1977, ranged from 1
to 369 months (mean, 8.0 years; SD, 6.7). Mortality during
the follow-up period included 31 (23.1%) of 134 survivors.
Actuarial survival in this group is depicted in Figure 3.
Survival at 5, 10, 15, and 20 years of follow-up was 83%,
73%, 61%, and 61%, respectively. Univariate analysis of
selected prognostic factors for early and late mortality are
listed in Table 4. Perioperative mortality was higher in
patients aged 5 years or younger at the time of the last
surgical procedure (P  .04). Late mortality appeared to be
more common in patients with major aortopulmonary col-
lateral arteries (P  .0182).
Group B is composed of 335 patients who underwent
complete repair during a single surgical stage or after mul-
Figure 1. Distribution of the patient population: group A, patients who underwent palliative procedures, recon-
structive procedures, or both but had not undergone complete repair; group B, patients who underwent complete
repair in a single surgical stage or after previous surgical stages. TOF, Tetralogy of Fallot; PA, pulmonary atresia;
MAPCA, major aortopulmonary collateral artery; systemic-PA, systemic–pulmonary artery; RVOT, right ventricular
outflow tract reconstruction; Uni, unifocalization procedures.
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tiple reconstructive procedures. Age at the time of complete
repair ranged from 1 day to 54.6 years (mean, 11.3 years;
SD, 9.23). Twenty-four patients underwent complete repair
during the first year of life. There were 2 (8.3%) surgical
deaths in this group. There were 160 male (47.8%) and 175
female (52.2%) patients. Ninety-six (28.6%) patients under-
went complete repair during a single surgical stage (mean
age at complete repair, 10.2 years; SD, 10.0; range, 1
day-43.77 years). The remaining 239 (71.3%) additional
patients in group B required a mean of 1.5 surgical proce-
dures before undergoing complete repair. In this latter group
mean age at the initial operation was 5.5 years (SD, 6.7;
range, 1 day-34.1 years); mean age at complete repair was
11.8 years (SD, 8.9; range, 1 day-54.6 years). Some of the
preliminary surgical stages were done at other institutions
before the first Mayo Clinic visit and may have occurred
before the onset of the study. Morphologic features of the
pulmonary arterial tree for all patients in group B is shown
in Table 5. Twelve (3.6%) patients had no central pulmo-
nary arteries, and 223 (66.5%) patients had major aortopul-
monary collateral arteries. Preliminary surgical procedures
are summarized in Table 6. One hundred sixty-eight patients
underwent a total of 198 systemic–pulmonary artery shunts
before complete repair. The median time interval between
initial shunt placement and complete repair was 4.5 years
(SD, 7). Eighty-nine patients underwent right ventricular
outflow tract reconstruction before complete repair. One
hundred twenty-three unifocalization procedures were per-
formed in 81 patients before complete repair, and 19 uni-
focalization procedures were performed in 19 patients dur-
ing complete repair. At the time of complete repair, 146
patients underwent surgical interruption of residual major
aortopulmonary arterial collaterals. At the end of complete
repair, the mean PRV/LV systolic pressure ratio for the
entire group was 0.66 (SD, 0.180). There was a significant
correlation between age at the time of complete repair and
resulting mean PRV/LV systolic pressure ratio (P  .007).
This difference did not appear to be clinically significant
because less than 3% of the variation in the PRV/LV sys-
tolic ratio was explained by age. Reopening of the ventric-
ular septal defect during complete repair was performed in
22 patients who were found to have excessively high right
ventricular pressures (PRV/LV systolic pressure ratio,
0.85).
Surgical mortality (30-day) for all group B patients was
4.5% (15 patients). Three of the early deaths occurred in the
group of patients who had their ventricular septal defects
reopened. Causes for early mortality are shown in Table 7.
Mortality in patients who underwent single-stage complete
repair was 7.8% versus 3% in those who had preliminary
surgical stages. Perioperative morbidity is shown in Table 8.
Respiratory failure requiring prolonged mechanical ventila-
tion was the most common postoperative complication,
occurring in 46 (66%) patients. Mean follow-up from com-
plete repair was 11.4 years (SD, 7.5; range, 1 month–23
years). Fifty-two (16.3%) of 320 operative survivors died
during the follow-up period. Causes of late death are shown
in Table 9, with cardiac failure and reactive airway disease
being the most common causes. Actuarial survival is shown
in Figure 4. Five-, 10-, 15-, and 20-year survival is shown in
Table 10. Univariate analysis of selected factors for late
TABLE 1. Group A: Morphologic characteristics
Morphology Patients No. (%)
Central PAs
Absent 23 (14.4)
Confluent, normal sized 1 (0.6)
Confluent, hypoplastic 101 (63.1)
Nonconfluent 33 (20.6)
Single 2 (1.3)
MAPCAs
Present 146 (91.2)
Absent 14 (8.8)
Other sources of pulmonary blood flow
Ductus arteriosus 16 (10)
Coronary-PA fistula 4 (2.5)
Ventricular septal defect
Single 155 (96.9)
Multiple 5 (3.1)
PA, Pulmonary artery; MAPCA, major aortopulmonary collateral artery.
TABLE 2. Group A: Surgical and catheter interventions
Interventions No.
Palliative procedures 81
RVOT reconstruction 98
Unifocalization 98
ASD closure 3
Pulmonary arterial confluence graft 14
Surgical interruption of MAPCAs 64
PA dilatation-stenting 4
PA dilation-stenting 13
Aortic valve replacement 14
RVOT, Right ventricular outflow tract; ASD, atrial septal defect; MAPCA,
major aortopulmonary collateral artery; PA, pulmonary artery.
TABLE 3. Group A: Causes of surgical mortality
Cause No. (%)
Cardiac
Low cardiac output 11 (6.9)
Arrhythmia 4 (2.5)
Myocardial infarction 2 (1.25)
Noncardiac
Bronchospasm-respiratory failure 7 (4.4)
Neurologic 2 (1.25)
Total 26 (16.3)
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mortality is shown in Table 11. Statistically significant
factors included reopening of the ventricular septal defect, a
PRV/LV systolic pressure ratio of greater than 0.7, male
sex, the need for a pulmonary artery confluence graft, and
late reoperation for extracardiac conduit replacement. Table
11 shows multivariate analysis for possible factors predic-
tive of death after complete repair. Reopening of the ven-
tricular septal defect was the single significant factor (P 
.0004). Freedom from reoperation is shown in Figure 5.
Late surgical and catheter interventions are shown in Table
12. One hundred sixteen patients have required surgical
revision of the right ventricular outflow tract during the
follow-up period. Four (3.4%) patients died during conduit
replacement at other institutions. The mean interval from
complete repair to the first revision of the right ventricular
outflow tract was 9.8 years (SD, 5.9). Twenty-one patients
of this group required more than one conduit replacement.
Twenty patients have required aortic valve repair or replace-
ment for progressive aortic insufficiency, and 29 patients
underwent closure of residual ventricular septal defect; 10
of these closures were in patients whose ventricular septal
defects had been reopened at the time of complete repair.
An effort was made to determine whether elevation of
the right ventricular pressure independent of conduit ob-
Figure 2. Surgical mortality for group A patients grouped under different time periods shows improvement in results
with time.
Figure 3. Kaplan-Meier actuarial survival for patients in group A after last surgical procedure.
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struction occurs in these patients after complete repair. Such
a change would reflect an increase in pulmonary arterial
resistance. Table 13 compares right ventricular pressure
measured intraoperatively after complete repair with that
measured after the first extracardiac conduit replacement.
These measurements would be independent of conduit ob-
struction. There was no significant change in right ventric-
ular pressure.
Discussion
The surgical management of patients with tetralogy of Fal-
lot and pulmonary atresia remains controversial and in a
TABLE 4. Group A: Selected variables for early mortality
univariate analysis
Variable No. (%) P value
Female sex 13 (16.5) .94*
Confluent PAs 17 (16.7) .40*
Coronary to PA fistula 1 (25) .51*
Age at last operation .04†
PA, Pulmonary artery.
*Statistical testing with the Fisher exact test comparing patient charac-
teristics within each respective group.
†Statistical testing with Wilcoxon rank sum test.
TABLE 5. Group B: Morphologic characteristics
Morphology
Single-stage
repair (n  96),
No. (%)
Multistage repair
(n  239),
No. (%)
Total
(n  335),
No. (%)
Central PAs
Confluent, normal size 22 (22.9) 28 (11.7) 50 (14.9)
Confluent, hypoplastic 58 (60.4) 162 (67.7) 220 (65.7)
Nonconfluent 11 (11.4) 39 (16.3) 50 (14.9)
Single 3 (3.1) 3 (0.9)
MAPCAs
Present 69 (71.8) 174 (72.8) 243 (72.5)
Absent 27 (28.1) 65 (27.1) 92 (27.5)
Other sources Qp
Ductus arteriosus 37 (38.5) 35 (14.6) 72 (21.5)
Diffuse SCAs 9 (9.3) 9 (2.6)
Coronary-PA fistula 8 (8.3) 3 (1.2) 11 (3.3)
Single VSD 92 (95.8) 235 (98.3) 327 (97.6)
PA, Pulmonary artery; MAPCA, major aortopulmonary collateral artery;
SCA, systemic collateral artery; Qp, pulmonary blood flow; VSD, ventricular
septal defect.
TABLE 6. Group B (n  335): Preliminary surgical proce-
dures before complete repair
Procedure No.
Systemic-PA shunt 198
Potts 8
Waterston 60
Blalock-Taussig (classic) 41
Blalock-Taussig (modified) 82
BDCPA 2
Mee procedure 5
RVOT reconstruction 89
Unifocalization 161
Before complete repair 142
At the time of complete repair 19
Pulmonary confluence prosthesis 52
Interruption of MAPCAs 156
Surgical 146
Coil embolization 10
Reopened VSD 22
BDCPA, Bidirectional cavopulmonary anastomosis; RVOT, right ventricular
outflow reconstruction; MAPCA, major aortopulmonary arterial collateral
artery; VSD, ventricular septal defect.
TABLE 7. Group B (n  335): Causes of early mortality
Cause No. (%)
Cardiac
Low cardiac output 10 (3.0)
Arrhythmia 2 (0.6)
Noncardiac
Bronchospasm 1 (0.3)
Neurologic 2 (0.6)
Total 15 (4.5)
TABLE 8. Group B (700 operations): Perioperative morbidity
Complication
No. of
events
(%)
Neurologic 5 (0.71)
Phrenic nerve injury 2 (0.28)
Reoperation for bleeding 21 (3.0)
Sepsis 36 (5.1)
Heart block (pacemaker) 4 (0.57)
Prolonged mechanical ventilation* 46 (6.6)
Pulmonary infarct 3 (0.42)
Tracheotomy 9 (1.3)
*More than 48 hours.
TABLE 9. Group B: Causes of late death (320 survivors of
complete repair)
Cause No. (%)
Cardiac
Cardiac failure 13 (4.0)
Arrhythmia 10 (3.1)
Noncardiac
Bronchospasm 8 (2.5)
Neurologic 1 (0.3)
Other* 5 (1.6)
Unknown 15 (4.7)
Total 52 (16.3)
*One patient died in a motor vehicle accident, one patient died of bleeding
at reoperation, one patient died in hepatic-renal failure, one patient died of
trauma, and one patient died suddenly while asleep.
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state of evolution. At the Mayo Clinic the focus has been on
the search for surgical techniques that would allow recon-
stitution of the right ventricular outflow tract and closure of
the ventricular septal defect (complete repair). Such goals
are easily reached when the pulmonary arterial size and
architecture are well preserved, as in the simple forms of the
anomaly.7 In our practice conditions for complete repair
have included a central pulmonary arterial area at least 50%
of normal size, the potential for incorporating at least 14
pulmonary segments to the right ventricular tract, a predom-
inant left-to-right shunt, and correctable stenotic lesions in
the pulmonary arterial tree. For patients with hypoplastic
pulmonary arteries, establishment of continuity between the
right ventricle and the hypoplastic pulmonary arterial con-
fluence with a nonvalved rigid conduit, leaving the ventric-
ular septal defect open, has been shown to induce pulmo-
nary arterial growth-dilatation, allowing for subsequent
closure of the ventricular septal defect in many patients,
particularly those without major arborization abnormali-
ties.8-11 For neonates and infants with hypoplastic central
pulmonary arteries, we have preferred direct anastomosis of
the hypoplastic main pulmonary artery to the ascending
aorta, as proposed by Watterson and colleagues.12 For those
patients with pulmonary arterial arborization abnormalities
and multiple major aortopulmonary collateral arteries, in-
corporation of an adequate number of pulmonary arterial
segments to the right ventricle has required ingenious sur-
gical maneuvers grouped under the term unifocalization
procedures. Such interventions have met with varied suc-
cess in improving the candidacy of patients for the final
intracardiac repair.13-16
The relative lack of symptoms and long survival seen in
some patients with these anomalies demand justification for
the need of aggressive and complex surgical procedures.17
In general terms a low surgical risk is mandatory to justify
interference with the natural history of the anomaly.
Clearly, surgical intervention is warranted in those symp-
tomatic patients with increasing cyanosis resulting from
reduced pulmonary blood flow. It is also indicated in those
patients with congestive heart failure caused by excessive
pulmonary blood flow. It is frequently indicated in those at
risk of losing pulmonary arterial segments because of pro-
gressive obstruction of major aortopulmonary collateral ar-
teries and in those whose morphologic characteristics ex-
pose them to pulmonary vascular obstructive disease. In
such circumstances palliation may be combined with recon-
structive procedures that result in improvement in the pul-
monary arterial architecture and prepare the patient for
possible complete repair. In those patients who are clinically
stable and enjoy acceptable levels of functional capacity,
elective reconstructive surgical procedures would appear to
Figure 4. Kaplan-Meier actuarial survival for patients in group B after complete repair.
TABLE 10. Group B: Long-term survival
Survival (%) Confidence interval
5 y 92 89–95
10 y 86 82–90
15 y 83 78–88
20 y 75 67–82
TABLE 11. Group B: Final multivariate (Cox model) assess-
ment of prognostic factors in mortality in patients under-
going complete repair
Variable Risk ratio
95% confidence
interval P value
Male sex 1.772 1.011–3.104 .0456
Reopening VSD 5.613 2.149–14.661 .0004*
Age at complete repair 1.028 1.001–1.055 .0449
VSD, Ventricular septal defect.
*Statistical significance, P  .001.
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be a reasonable option when the pulmonary and collateral
arterial circulation appears amenable to surgical improve-
ment, when the risks of such surgical interventions appear to
be low, and when the possibilities of success are high. Thus,
careful assessment of individual patients is mandatory.
Our patient population is skewed toward the older age
groups, reflecting the nature of our practice. Thus, our
experience with neonates is limited. Repair of the simple
forms of the anomaly in infants and small children has been
reported by DiDonato and colleagues.18 Although our ex-
perience confirms the feasibility of surgical repair of this
anomaly in small children and infants, our preference has
been to indicate single-stage repair in selected patients. We
have followed with interest the experience of Hanley and
others who have proposed an aggressive, uniform surgical
approach for the child born with this anomaly.19-21 The use
of the midline approach for complex single-stage unifocal-
ization procedures has allowed a concerted effort directed at
the treatment of all neonates born with the anomaly rather
than focusing only on the selected survivors of the first few
years in life.
After complex unifocalization procedures in infants,
methods have been proposed to determine intraoperatively
which ventricular septal defects can be closed with resulting
adequate right ventricular pressure. These methods rely on
estimation of the total pulmonary resistance by means of
continuous perfusion with a roller pump.19-22 Our prefer-
ence has been to complete the repair and to measure right
and left ventricular systolic pressures by means of direct
needle puncture after discontinuation of cardiopulmonary
bypass. Those patients in whom the PRV/LV systolic pres-
sure ratio is greater than 0.85 have the ventricular septal
defect reopened before completion of the surgical proce-
dure.
Reactive airway disease has been an important cause of
mortality and morbidity in patients undergoing surgical
procedures for this anomaly. In our series cardiorespiratory
events were the most common cause of early and late death
in both group A and B patients. Bronchospastic episodes
appear to be particularly common in patients with associ-
ated velocardiofacial syndrome.23
Patients who underwent staged reconstruction up to and
including complete repair had the lowest perioperative mor-
tality of all groups (3%). Single-stage repair in our series
had a perioperative mortality of 7.8%. This fact supports our
contention that the staged approach may be associated with
less surgical risk, particularly in patients with complex
pulmonary arterial circulation, absent central pulmonary
arteries, and the presence of major aortopulmonary arterial
collaterals. Our mortality for single-stage repair was similar
to that reported in other series.24,25
The need to reopen the ventricular septal defect at the
time of attempted complete repair (n  22, 6.5%) was a
significant factor for early (P  .001) and late (univariate
P  .0007 and multivariate P  .00004) mortality. This
TABLE 12. Group B: Number and types of interventions after
complete repair
Intervention
Interval (y)*
Mean SDNo.
No. of
patients
RV-PA conduit revision 137 116† 9.8 5.9
Reclosure of VSD 29 29 6.1 6.2
Coil embolization 18 11 6.7 5.2
PA dilation (balloon-stent) 67 51 5.4 5.6
Aortic valve replacement 27 20 10.5 8.7
Tricuspid annuloplasty 10 10 14.8 9.8
RV-PA, Right ventricle–pulmonary artery; VSD, ventricular septal defect;
PA, pulmonary artery.
*Interval is from complete repair to first reoperation.
†Twenty-one of 116 patients underwent more than one conduit reopera-
tion.
Figure 5. Freedom from reoperation for patients in group B after complete repair.
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reflects the presence of intolerably high right ventricular
pressures and unfavorable pulmonary arterial anatomy. The
mean PRV/LV systolic pressure ratio for patients who un-
derwent successful closure of the ventricular septal defect
was 0.64. Although our policy has been to reopen the
ventricular septal defect when the ratio is higher than 0.85,
this study suggests that a ratio of greater than 0.7 is asso-
ciated with higher early mortality (P  .002). Ten of 21
survivors of ventricular septal defect reopening underwent
successful late closure of the defect, usually after pulmonary
arterial runoff was improved by means of catheter interven-
tions.
It is not yet clear whether a single-stage approach should
be offered to all affected patients born with this anomaly. In
our practice we have selected, for this approach, only those
small children and infants with normal-sized or mild hy-
poplasia of the pulmonary arterial confluence and with
accessible major aortopulmonary collateral arteries. All
other patients continue to be treated with the staged ap-
proach.
Patients who have had successful repair are not free from
the need for further surgical therapy. Revision of the right
ventricular outflow tract has been the most common late
intervention. One hundred sixteen patients underwent 137
conduit replacements. Given the results obtained with the
available extracardiac conduits,26 this is not likely to change
significantly in the near future. Reclosure of residual or
recurrent ventricular septal defects, which contribute to
right ventricular hypertension, has been necessary and re-
warding in some patients. Late development of aortic valve
insufficiency has required aortic valve replacement or re-
pair, a procedure often scheduled in conjunction with re-
placement of extracardiac conduits. Repeat cardiac cathe-
terization with balloon dilatation, stenting of residual areas
of stenosis, or both in the pulmonary arteries has been
helpful in reducing pulmonary arterial resistance and in
helping to optimize the distribution of pulmonary arterial
blood flow.
Although the mere prosthetic replacement of missing or
unusable segments of the pulmonary arterial tree has been
shown to be possible with reported surgical techniques,27,28
such interventions do not obviate the problem of lack of
growth of the prosthesis and of scarring or stenosis of
surgical anastomotic sites. The surgeon’s inability to dis-
tribute the pulmonary blood flow equally to all available
pulmonary arterial segments can have significant conse-
quences for the repaired patient, particularly in terms of
progression of pulmonary hypertension and ventilation-
perfusion mismatch. These difficulties are proportional to
the complexity of the pulmonary arterial malformation, and
even with the help of catheter interventional techniques
(balloon dilatation, stenting, or both), the results obtained
with complex reconstructive techniques (unifocalization
procedures) may not result in adequate decompression of
the right ventricle. Careful follow-up of these patients is
mandatory.
In conclusion, our series confirms that patients with
tetralogy of Fallot and pulmonary atresia with complex
malformations of the pulmonary arterial circulation can
undergo complex reconstructive surgical procedures that
prepare them for complete repair. The surgical risk of such
interventions appears to be acceptable and can be mini-
mized by prudent staging of the complex surgical interven-
tions. Complete repair can be undertaken during a single
surgical stage in selected patients in whom the malforma-
tion affecting the pulmonary arterial tree can be corrected
during a midline sternotomy approach. Long-term survival
is possible after corrective operations, although patients
continue to require reinterventions, particularly for replace-
ment of obstructed or incompetent valved extracardiac con-
duits. Balloon dilatation, stenting, or both of residual areas
of obstruction in the reconstructed pulmonary arteries are
important for improvement in the distribution of pulmonary
arterial blood flow.29,30 Surgical reconstruction can be in-
dicated in patients with a well-balanced physiology with
few symptoms when their pulmonary arterial anatomy of-
fers good opportunities for unifocalization and eventual
complete repair.
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Discussion
Dr William G. Williams (Toronto, Ontario, Canada). Dr Cho
and his colleagues are to be congratulated for presenting their very
extensive experience with pulmonary atresia and ventricular septal
defect and for illustrating the complete spectrum of pathology of
this lesion.
The nomenclature pulmonary atresia–ventricular septal defect
is somewhat unfortunate because it is a single name for an entity
of many faces. It is appropriate for the Mayo Clinic group to
present these data because the first extracardiac nonvalved conduit
used for repair of this condition was inserted at the Mayo Clinic
when Dr John Kirklin created a pericardial tube connecting the
right ventricle to the pulmonary artery. His sentinel patient did
well for more than 20 years after repair, and this gives rise to my
first question. What is your current policy regarding the use of
nonvalved conduits for palliation or repair of pulmonary atresia–
ventricular septal defect? There are 137 conduit reoperations
among the surviving patients: What do you recommend for those
requiring conduit replacement, valve or no valve, and which type
of connection?
Pulmonary atresia–ventricular septal defect, at the favorable
end of the morphologic spectrum, is a close cousin of tetralogy; the
management and outcomes are similar. In contrast, patients with
nonconfluent and, indeed, absent pulmonary arteries are at the
other end of the spectrum, and either palliation or repair is prob-
lematic.
As you have shown, these patients require unifocalization of
their aortopulmonary collaterals to a single source of blood supply
and then either connection to an arterial shunt, such as a Blalock-
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Taussig shunt, or to the heart, with or without ventricular septal
defect repair. The surgical alternatives may be a thoracotomy and
unifocalization of one lung at a time or median sternotomy with
reconstruction of both sides.
My second question is this: Given your extensive experience,
what do you currently recommend as a protocol for managing
those patients with nonconfluent, plus or minus absent, pulmonary
arteries?
To be critical of your analysis, I think it was counterproductive
to create 2 subgroups at the outset, in this case palliation only
versus attempted repair. The power of the data would be greater if
all 495 patients were included in the analysis to look for statistical
correlations with, for example, successful repair as the outcome
variable. One can then address the obvious question among others:
Does the initial operation affect the probability of the patient
having a successful repair?
Although the 2 groups you have created are clinically relevant,
they are not entirely clean. The palliation group includes 45
patients who may undergo repair at some point when their assess-
ment is completed, and conversely, the attempted repair group
contains 22 patients in whom the ventricular septal defect had to be
reopened, and they are therefore palliated.
The data set, of necessity, contains a plethora of numbers, and
Dr Cho has done an excellent job in helping us understand the data.
The bottom line, if my calculations are correct, is that successful
repair was achieved in 60% of the 495 patients. That may reach as
high as 70% if the current patients awaiting assessment undergo
repair. Although 60% may seem disappointing, it is a considerable
improvement over about 10 years ago, when only a third of these
patients were undergoing repair. Have you analyzed the trend
toward the increasing numbers of patients who are amenable to
complete repair over time? What do you estimate as the probability
of complete repair in the present era for a patient with pulmonary
atresia–ventricular septal defect?
Finally, there are some older patients with ventricular septal
defect who present as adults, usually with previous palliation.
These patients tend to have a good long-term outlook in terms of
survival. What is your current indication for intervention in the
adult with pulmonary atresia–ventricular septal defect?
Dr Cho. Thank you, Dr Williams. I will answer these questions
in order.
The first question concerned when to consider the use of a
nonvalved conduit. In patients who have hypoplastic pulmonary
arteries and pulmonary arteries that we would want to grow, we
usually use a nonvalved conduit.
After repair, our preference has been the use of a valved
conduit. We do not use nonvalved conduits on the basis of the
criteria for complete repair. Patients had to have a pulmonary
artery size greater than 50% of normal. We believe that is signif-
icant enough to allow for successful complete repair, although, as
you saw, 6.5% of the patients did have to undergo reopening of the
ventricular septal defect, probably as a result of the underlying
morphology in the branch pulmonary arteries.
As to the third question, concerning management of noncon-
fluent pulmonary arteries, we use a pulmonary artery confluence
graft. It is a T graft. Fifty-one patients had placement of a conflu-
ence graft, of whom 9 patients had placement before complete
repair. The other 42 patients had placement of that T graft con-
nected to the right ventricular outflow tract reconstruction at the
time of complete repair.
What is the probability of complete repair in this patient pop-
ulation? It is a diverse population, and perhaps at the end of this
discussion, Dr Puga might comment on that. I always tell folks that
if I could predict the future, I would bet on the ponies in Vegas.
And I do not think anyone has that answer for this disease process.
Current indications for an adult patient, I think, depend on
symptoms. If a patient has cyanosis or congestive heart failure, I
think he or she should undergo some sort of palliation and a
possible reconstructive procedure, right ventricular outflow tract
reconstruction, or unifocalization leading to a potential complete
repair at a later date.
Where the controversy lies is in those patients who are not
symptomatic. If they have favorable morphology and if you can
perform this operation with a low risk of mortality, as I believe that
we have been able to demonstrate with the numbers, I believe that
these patients should be offered an operation. The reason why they
may be relatively asymptomatic is that they have a balanced
physiology, but that can change.
Dr Christo I. Tchervenkov (Montreal, Quebec, Canada). I
would like to acknowledge the significant contributions of the
Mayo Clinic in the treatment of this difficult group of patients.
I would like to echo some of the comments that Dr Williams
made and actually take the discussion a little bit further. Pulmo-
nary atresia–ventricular septal defect is an extremely heteroge-
neous malformation with tremendous variation in the pulmonary
circulation. On one end of the spectrum, patients with pulmonary
atresia–ventricular septal defect have only native pulmonary arter-
ies, and at the other end, they only have major aortopulmonary
collateral arteries (MAPCAs) and no native pulmonary arteries. To
clump all these morphologic characteristics together does cloud
the picture in terms of statistical analysis and may prevent us from
getting useful information that should be obtained from such a
large series as to the optimal surgical approach for each subgroup.
In the Nomenclature Supplement of The Annals of Thoracic
Surgery in April 2000, we suggested that these patients should be
divided into 3 broad groups simply on the basis of the presence or
absence of native pulmonary arteries (NPAs) and MAPCAs. In
pulmonary atresia–ventricular septal defect type A there are only
NPAs and no MAPCAs, in type B there are both NPAs and
MAPCAs, and in type C there are only MAPCAs and no NPAs.
Because patients in these 3 groups may require different initial
and subsequent treatment strategies and have different outcomes,
have you tried to analyze your data with almost 500 patients in that
fashion? If you have have not done so, I would certainly hope that
you would consider doing that.
Dr Cho. We have not analyzed it with respect to that classifi-
cation. However, for patients who have a favorable anatomy, we
have proceeded with a single-stage complete repair to include
unifocalization in a number of patients. But they have to meet the
criteria that I listed, and the major aortopulmonary collaterals have
to be accessible through the midline. We performed unifocaliza-
tion in 19 patients, of whom 10 underwent single-stage complete
repair with unifocalization. Nine patients, as their last operation
with complete repair, underwent some component of unifocaliza-
tion and complete repair.
Surgery for Congenital Heart Disease Cho et al
80 The Journal of Thoracic and Cardiovascular Surgery ● July 2002
CH
D
I thank you for your comments, but we have not specifically
looked at that.
Dr Vadiyala M. Reddy (San Francisco, Calif). Dr Cho, I
would like to echo the same concerns about clamping all these
patients. At least the patients who have confluent central pulmo-
nary arteries without a significant source of collaterals should
probably be separated from this if the 2 pulmonary arteries are all
supplying the entire lung. The prognosis and outcome in these
patients would be completely different when compared with that in
patients who have part of the lung at least supplied by the collat-
erals in association with the pulmonary arteries.
I have a few questions for you.
What pulmonary/systemic blood flow ratio would you recom-
mend during a complete repair, because I know you have a
substantial number of patients in whom you had to reopen the
ventricular septal defect? One of the criteria you listed was pre-
dominant left-to-right shunt as an indication for a complete repair.
Do you have an actual number for that? If you used an actual
number, was it predictive of ventricular septal defect closure in all
patients, or was it not?
The other question I have for you is this: From your data in the
second group, about 70% or 72% of the patients had predominant
supply from collaterals; however, you have unifocalized only 30%
of the patients. Would unifocalizing more patients have increased
the pulmonary bed to achieve a lower PRV/LV ratio or a lesser rate
of reopening of the ventricular septal defect?
Dr Cho. Thank you, Dr Reddy. We do not have a specific
pulmonary/systemic blood flow ratio before repair, but we do have
one after complete repair, as you saw. Those patients whom we
checked with a 21-gauge spinal needle catheter, if they have a
PRV/LV systolic ratio of greater than 0.85, we will automatically
reopen that ventricular septal defect.
Dr Francisco J. Puga (Rochester, Minn). I just want to make
a couple of brief comments.
One of the reasons we divided the patient population in this
fashion is to compare the fate of patients with and without repair.
Clearly, these 2 groups are exposed to different late events given
their different hemodynamic conditions and, to some degree, the
differences in pulmonary arterial morphologic features. The fact is
that the survival curves are different for these 2 groups.
Management of patients with nonconfluent pulmonary arteries
in our current experience is pretty much as stated in the presenta-
tion. In infants, though, we do not like to approach them with
midline unifocalization if they are going to require a central
prosthesis because this creates a tremendous future problem for the
child. We believe that single-stage repair is indicated if the pul-
monary arterial reconstruction can be achieved with their native
tissue.
The question regarding pulmonary/systemic blood flow ratio
does not really pertain to the selection of patients for complete
repair because most of these patients have persistent stenotic areas
in the pulmonary arterial tree, many of which can be resolved in
the operating room by surgical means or with intraoperative stent-
ing. It would only be significant in the patient who has a wide,
open pulmonary artery circulation or the patient with unresolvable
obstructive lesions, situations that happen only rarely.
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